ArticleMolecular therapy oncolytics2019

High-Affinity DARPin Allows Targeting of MeV to Glioblastoma Multiforme in Combination with Protease Targeting without Loss of Potency.

Jan R H Hanauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.